GSK shares dive as weaker vaccine sales and restructuring charges unnerve investors

British pharma company reports declining profits amid concerns over looming patent loss for blockbuster HIV drug Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better than expected financial results, as investors were unnerved…